Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2017 2
2018 1
2019 1
2020 3
2022 1
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
The Toxicology Investigators Consortium 2022 Annual Report.
Amaducci AM, Campleman SL, Li S, Karshenas DL, Spyres MB, Farrugia LA, Kang AM, Culbreth RE, Wax PM, Brent J, Aldy K; Toxicology Investigators Consortium Study Group. Amaducci AM, et al. J Med Toxicol. 2023 Oct;19(4):313-340. doi: 10.1007/s13181-023-00962-2. Epub 2023 Aug 29. J Med Toxicol. 2023. PMID: 37644342
The Toxicology Investigators Consortium Case Registry-the 2021 Annual Report.
Love JS, Karshenas DL, Spyres MB, Farrugia LA, Kang AM, Nguyen H, Campleman SL, Li S, Wax PM, Brent J, Aldy K; Toxicology Investigators Consortium Study Group. Love JS, et al. J Med Toxicol. 2022 Oct;18(4):267-296. doi: 10.1007/s13181-022-00910-6. Epub 2022 Sep 7. J Med Toxicol. 2022. PMID: 36070069 Free PMC article.
Heart failure in the Veneto region of Italy: analysis of therapeutic pathways and the utilization of healthcare resources.
Degli Esposti L, Perrone V, Sangiorgi D, Pitotti C, Ritrovato D, Menti AM, Scroccaro G, Mantoan D, Bellometti SA, Andretta M. Degli Esposti L, et al. Among authors: pitotti c. Expert Rev Pharmacoecon Outcomes Res. 2020 Oct;20(5):499-505. doi: 10.1080/14737167.2020.1718494. Epub 2020 Jan 23. Expert Rev Pharmacoecon Outcomes Res. 2020. PMID: 31971025
Cost Effectiveness of the Long-Acting β2-Adrenergic Agonist (LABA)/Long-Acting Muscarinic Antagonist Dual Bronchodilator Indacaterol/Glycopyrronium Versus the LABA/Inhaled Corticosteroid Combination Salmeterol/Fluticasone in Patients with Chronic Obstructive Pulmonary Disease: Analyses Conducted for Canada, France, Italy, and Portugal.
Reza Maleki-Yazdi M, Molimard M, Keininger DL, Gruenberger JB, Carrasco J, Pitotti C, Sauvage E, Chehab S, Price D. Reza Maleki-Yazdi M, et al. Among authors: pitotti c. Appl Health Econ Health Policy. 2016 Oct;14(5):579-94. doi: 10.1007/s40258-016-0256-z. Appl Health Econ Health Policy. 2016. PMID: 27516088